Loading video...

Video Failed to Load

Go Home

Professor Angus Dalgleish, a distinguished virologist, oncologist, immunologist, and Professor Emeritus at St George's University of London, drew on his extensive expertise to highlight the significant adverse effects associated with mRNA vaccines. He is the author or co-author of over 500 peer reviewed scientific papers and over 70 chapters...

47,131 views • 10 months ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

💥Neale Hanvey in the UK Parliament Excess Deaths Debate mentioned the concerns of London Professor of Oncology, and principal of the Institute for Cancer Vaccines and Immunotherapy, Professor Angus Dalgleish in this 20m speech below. "According to the University of London Professor of Oncology, and principal of the Institute for Cancer Vaccines and Immunotherapy, Professor Angus Dalgleish, this has precipitated various serious and sometimes fatal consequences due to antibody development mediated by the spike protein. I will not go into the detail of that, but at a meeting convened by the hon. Member for North West Leicestershire, Professor Dalgleish told us that the UK Government and their agencies are in serious denial about this issue, resulting in many deaths being poorly understood" [NEALE CONTINUED FURTHER] “a sequence that is ‘used to drive DNA into the nucleus, especially in gene therapies’ and that this is ‘something that regulatory agencies around the world have specifically said is not possible with the mRNA vaccines’. These SV40 promotors are also well recognised as being oncogenic”— or cancer-inducing genetic material. Other scientists have confirmed those findings. Professor Dalgleish further notes: “To put it bluntly, this means that they are not vaccines at all but a…Genetically Modified Organism that should have been subject to totally different regulatory conditions and certainly not be classed as vaccines.” Worryingly, Professor Dalgleish also notes that oncologists have contacted him from across the world, and the consensus is that this is thought to be precipitating relapse in melanoma, lymphoma, leukaemia and kidney cancers. He concludes with the following warning - To advise booster vaccines, as is the current case, is no more and no less than medical incompetence" It appears that this specialist DR in Japan shares concerns similar to this specialist Oncologist in the United Kingdom, Professor Angus Dalgleish

Humanspective

19,440 views • 2 years ago

A prominent oncologist is sounding a major alarm, reporting a disturbing and repeated pattern of cancer relapse and new onset following COVID-19 booster vaccines. Professor Angus Dalgleish, a renowned Professor of Oncology at St. George’s, University of London, and a Consultant Medical Oncologist with decades of experience, has shared a deeply concerning clinical observation. He reports that in his own practice, he has now identified at least 6 to 8 patients with long-term stable melanoma (stage 4) who have suffered aggressive disease relapses shortly after receiving a booster. These are not minor recurrences but significant progressions requiring systemic therapy. Crucially, the patients themselves reported a sudden and drastic decline in health post-booster, describing severe fatigue and "long Covid-like" symptoms weeks or months before the relapse was clinically confirmed. Furthermore, Professor Dalgleish notes this pattern is not isolated to melanoma or to relapse. Within his personal and professional network, he is aware of multiple individuals—with no prior history of cancer—who developed severe symptoms after the booster, were subsequently investigated, and were diagnosed with new leukemias and lymphomas. His professional conclusion: this is beyond coincidence. The temporal link between the booster shot, the onset of debilitating symptoms, and the subsequent rapid progression or appearance of cancer is a pattern he can no longer ignore. He is calling for an immediate, collaborative investigation into this potential effect and urges for a halt to booster rollouts until this serious signal is thoroughly examined. This is a critical warning from a senior clinician on the front lines of cancer care.

Camus

41,366 views • 10 months ago